Correlation Between Eventide Healthcare and Fs Multi-strategy

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eventide Healthcare and Fs Multi-strategy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eventide Healthcare and Fs Multi-strategy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eventide Healthcare Life and Fs Multi Strategy Alt, you can compare the effects of market volatilities on Eventide Healthcare and Fs Multi-strategy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eventide Healthcare with a short position of Fs Multi-strategy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eventide Healthcare and Fs Multi-strategy.

Diversification Opportunities for Eventide Healthcare and Fs Multi-strategy

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Eventide and FSMSX is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Eventide Healthcare Life and Fs Multi Strategy Alt in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fs Multi Strategy and Eventide Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eventide Healthcare Life are associated (or correlated) with Fs Multi-strategy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fs Multi Strategy has no effect on the direction of Eventide Healthcare i.e., Eventide Healthcare and Fs Multi-strategy go up and down completely randomly.

Pair Corralation between Eventide Healthcare and Fs Multi-strategy

Assuming the 90 days horizon Eventide Healthcare Life is expected to generate 7.6 times more return on investment than Fs Multi-strategy. However, Eventide Healthcare is 7.6 times more volatile than Fs Multi Strategy Alt. It trades about 0.25 of its potential returns per unit of risk. Fs Multi Strategy Alt is currently generating about 0.28 per unit of risk. If you would invest  3,054  in Eventide Healthcare Life on May 19, 2025 and sell it today you would earn a total of  627.00  from holding Eventide Healthcare Life or generate 20.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Eventide Healthcare Life  vs.  Fs Multi Strategy Alt

 Performance 
       Timeline  
Eventide Healthcare Life 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eventide Healthcare Life are ranked lower than 19 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical indicators, Eventide Healthcare showed solid returns over the last few months and may actually be approaching a breakup point.
Fs Multi Strategy 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fs Multi Strategy Alt are ranked lower than 22 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Fs Multi-strategy is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eventide Healthcare and Fs Multi-strategy Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eventide Healthcare and Fs Multi-strategy

The main advantage of trading using opposite Eventide Healthcare and Fs Multi-strategy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eventide Healthcare position performs unexpectedly, Fs Multi-strategy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fs Multi-strategy will offset losses from the drop in Fs Multi-strategy's long position.
The idea behind Eventide Healthcare Life and Fs Multi Strategy Alt pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Valuation
Check real value of public entities based on technical and fundamental data